Analyze DCF forecasts for the company and compare them with competitors.
135.24M
Revenue has increased from the previous period.
10.76%
Revenue growth rate is unchanged from the previous period.
51.07M
EBITDA has increased from the previous period.
37.76%
EBITDA margin is unchanged from the previous period.
25.24M
EBIT has increased from the previous period.
18.66%
EBIT margin is unchanged from the previous period.
25.83M
Depreciation has increased from the previous period.
34.77M
Total cash has increased from the previous period.
25.71%
Cash percentage is unchanged from the previous period.
1.52M
Receivables have increased from the previous period.
1.13%
Receivables percentage is unchanged from the previous period.
4.26M
Inventories have increased from the previous period.
3.15%
Inventory percentage is unchanged from the previous period.
10.68M
Accounts payable has increased from the previous period.
7.89%
Payables percentage is unchanged from the previous period.
-54.93M
Capital expenditure has increased from the previous period.
-40.61%
CapEx percentage is unchanged from the previous period.
7.76%
WACC is unchanged from the previous period.
7.62%
Cost of equity is unchanged from the previous period.
7.84%
Cost of debt is unchanged from the previous period.
0.71
Beta is unchanged from the previous period.
18.44M
Diluted shares outstanding is unchanged from the previous period.
232.97M
Total debt is unchanged from the previous period.
132.07M
Total equity is unchanged from the previous period.
365.04M
Total capital is unchanged from the previous period.
63.82%
Debt weighting is unchanged from the previous period.
36.18%
Equity weighting is unchanged from the previous period.
25.24M
EBIAT has increased from the previous period.
-3.38M
UFCF has decreased from the previous period.
1.00%
Long-term growth rate is unchanged from the previous period.
-68.66M
Terminal value is unchanged from the previous period.
-61.06M
Enterprise value is unchanged from the previous period.
213.54M
Net debt is unchanged from the previous period.
-274.61M
Equity value is unchanged from the previous period.
-14.89
Equity value per share is unchanged from the previous period.
Analyze analyst forecasts for the company and compare them with competitors.
175.98M
The estimated revenue has increased from the previous period.
66.45M
The estimated EBITDA has increased from the previous period.
2.64
The estimated EPS has increased from the previous period.
48.77M
The estimated net income has increased from the previous period.
32.84M
The estimated EBIT has increased from the previous period.
21.85M
The estimated SG&A expenses have increased from the previous period.
View analysts' price targets and recommendations, and compare them with competitors.
$15.00
Analysts expect the stock price to increase by 106.19%.
Buy
Positive consensus among analysts.
7.00 - 7.33
4.78 - 12.65
206.2K / 110.0K (Avg.)
5.73 | 1.27